Phase 4
Completed N=50
The Effect of Adding Sufentanyl to Bupivacaine in Transversus Abdominis Plane Block to Reduce the Narcotic Dosage and Pain After Cesarean Delivery
Source: ClinicalTrials.gov NCT01516268 ↗Enrolled (actual)
50
Serious AEs
8.0%
Results posted
Mar 2013
Primary outcomePrimary: Narcotic Dosage
Summary
Adding sufentanyl to bupivacain in Transversus Abdominis Plane (TAP) block under ultrasound guide can reduce narcotic dosage, side effects and pain after cesarean delivery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Narcotic Dosage |
37.2; 52.8 | — |
| SECONDARY Pain |
— | — |
Eligibility Criteria
Inclusion Criteria
- female 18 to 40 Years
- class ASA 1 and 2
- candidates for elective cesarean section
Exclusion Criteria
- renal failure
- liver failure
- cardiac disorder
- coagulopathy
- hepatomegaly
- splenomegaly
- drug sensitivity and abuse
- morbid obesity
- smoking
- history of post operative nausea and vomiting
- motion sickness
- local hypoesthesia
Data sourced from ClinicalTrials.gov (NCT01516268). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.